<DOC>
	<DOCNO>NCT01139489</DOCNO>
	<brief_summary>This randomize controlled trial compare standard-of-care therapy infection critically ill patient procalcitonin-guided approach evaluate efficacy ( antibiotics consumption ) safety ( mortality ) .</brief_summary>
	<brief_title>Safety Efficacy Procalcitonin Guided Antibiotic Therapy Adult Intensive Care Units ( ICU 's )</brief_title>
	<detailed_description>Antibiotics prescribe widely intensive care unit link high cost occurence antimicrobial ( multi ) resistance . The optimal duration antibiotic treatment poorly know often base consensus guideline . SAPS multicenter , prospective , randomize , control open-label trial evaluate equivalence/efficacy safety procalcitonin-guided treatment infection ICU patient versus standard-of-care approach . All patient admit ICU systemic antibiotic prescribe presumed proven bacterial infection eligible trial . Patients randomize stratified accord clinical diagnosis severe sepsis septic shock . Any patient age 18 , admit ICU receive antibiotic assume infection enrol trial . Informed consent obtain write patient his/her relatives prior inclusion . In intervention group daily procalcitonin level perform generate non-binding stopping advice predefined stopping-rules reach . The ultimate decision stop antibiotic discretion physician group .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<criteria>Age 18 year old receiving antibiotic 24 hour assume proven infection Informed consent Failure obtain write consent participate Patients receive prolonged antibiotic therapy ( &gt; 3 week , e.g . endocarditis , cerebral/hepatic abscess ) Patients severe infection due virus parasite ( e.g . Dengue , Toxoplasma gondii , Plasmodium spp . ) Patients infected Mycobacterium tuberculosis Patients enter ICU postoperative observation and/or antibiotic prophylaxis estimate length stay le 24 hr . Patients suffer cystic fibrosis Severely immunocompromised patient patient HIV CD4 count le 200 cells/mm , neutropenic patient ( &lt; 500 neutrophil per mL ) patient solid organ transplantation Moribund patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Procalcitonin</keyword>
	<keyword>antibiotic therapy</keyword>
	<keyword>antibiotic</keyword>
	<keyword>sepsis</keyword>
	<keyword>infection</keyword>
	<keyword>biomarker</keyword>
</DOC>